Oncology Nurse Advisor » Lung Cancer
76 FOLLOWERS
This section of the Oncology Nurse Advisor Blog features the latest Lung Cancer News and Updates. Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
Oncology Nurse Advisor » Lung Cancer
2d ago
The pooled incidence of chemoradiation-induced grade 3-5 pneumonitis was 3.62% in randomized trials, 5.98% in observational studies, and 7.85% in observational studies of platinum doublet chemotherapy ..read more
Oncology Nurse Advisor » Lung Cancer
1w ago
Researchers found no association between BMI and outcomes of front-line chemoimmunotherapy in patients with advanced NSCLC ..read more
Oncology Nurse Advisor » Lung Cancer
2w ago
Results of a meta-analysis suggest that neoadjuvant chemoimmunotherapy is superior to neoadjuvant chemotherapy for patients with non-small cell lung cancer ..read more
Oncology Nurse Advisor » Lung Cancer
3w ago
Adding amivantamab to chemotherapy can improve progression-free survival in patients with previously untreated, advanced non-small cell lung cancer with EGFR exon 20 insertions, phase 3 data suggest ..read more
Oncology Nurse Advisor » Lung Cancer
3w ago
Adding chemotherapy to osimertinib improved progression-free survival in a phase 3 trial of patients with EGFR-mutated, advanced NSCLC ..read more
Oncology Nurse Advisor » Lung Cancer
3w ago
The application is supported by data from the randomized, phase 3 eXalt3 study ..read more
Oncology Nurse Advisor » Lung Cancer
1M ago
ASCO has released updated guidelines for the treatment of stage IV NSCLC with driver alterations ..read more
Oncology Nurse Advisor » Lung Cancer
1M ago
Older adults with PD-L1+ NSCLC may fare better if they receive immunotherapy rather than chemoimmunotherapy, data suggest ..read more
Oncology Nurse Advisor » Lung Cancer
1M ago
Adding perioperative tislelizumab to neoadjuvant chemotherapy and surgery can improve outcomes in patients with NSCLC, a phase 3 trial suggests ..read more
Oncology Nurse Advisor » Lung Cancer
1M ago
The kinase inhibitor was previously approved for this indication under the FDA’s accelerated pathway based on overall response rate and duration of response ..read more